Effect of 5-hydroxytryptophan and melatonin supplementation on mood, sleep and cognition in adult patients with depression
Abstract
5-Hydroxytryptophan (5-HTP) is a precursor to serotonin and has been used as an antidepressant. Its antidepressant potential has been evaluated under different experimental conditions with moderate results. However, it is considered to have poor pharmacokinetics and its use as an alternative treatment for mood disorders has even been questioned. This disadvantage seems to disappear when slow-release 5HTP is used. This study determined whether the combination of slow-release 5-HTP plus the combination with melatonin can reduce symptoms in patients who reported depression. This research consisted of a pre-experimental observational method (qualitative and quantitative). The participants were 20 adults between 25 and 50 years old with a previous diagnosis of depression issued by a mental health professional. Baseline values of depression, sleep quality, and working memory were measured. Subsequently, the participants were randomly assigned to the control group (n = 10) or the experimental group (n = 10). The control group only received information on general aspects of depression, while the experimental group received the combination of 100 mg of 5HTP/10 mg of melatonin for 1 month. The results indicated an improvement in mood, quality of sleep, and both verbal and visual working memory. It is concluded that the tested combination can be an effective alternative to the use of antidepressants.
How strong is the evidence?
Evidence Hub reads this as a randomized trial, done in people. Its evidence level is 3 of 5 (Moderate · trial / cohort / secondary analysis). Trials without a large randomized design, cohorts and secondary analyses give moderate evidence. Reported size: 20 participants or records.
Read the paper
Related studies
- Tryptophan Metabolism and Gut-Brain Homeostasis
- Rationale for a Multi-Factorial Approach for the Reversal of Cognitive Decline in Alzheimer’s Disease and MCI: A Review
- Prioritized Research for the Prevention, Treatment, and Reversal of Chronic Disease: Recommendations From the Lifestyle Medicine Research Summit
- Relationship between sleep disorders and gut dysbiosis: what affects what?
- The role of CLOCK gene in psychiatric disorders: Evidence from human and animal research
- Genetic, Transcriptome, Proteomic, and Epidemiological Evidence for Blood-Brain Barrier Disruption and Polymicrobial Brain Invasion as Determinant Factors in Alzheimer’s Disease
Go deeper in Evidence Hub
Evidence Hub adds a study data sheet (design, sample size, evidence level, key numbers), an AI summary and a chat grounded in the paper's text.